SCTX compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

SCTXScribe Therapeutics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

SCTXScribe Therapeutics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SCTX 5

BIIBBiogencustomer

SNYSanoficustomer

—Acuitas Therapeuticsunlistedsupplier

—The Regents of the University of Californiaunlistedsupplier

1 more · SCTX chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

SCTXScribe Therapeutics, Inc.

15.58· pre 15.12· delayed

Mkt cap$38.3MRevenue$2MQ2 FY26Revenue—

AMGNAmgen Inc

461.49· pre 448.50· delayed

Pre-marketNov 6 '26delayed

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

Pre-marketNov 6 '26delayed

SCTXScribe Therapeutics, Inc.

AMGNAmgen Inc

15.58pre 15.12delayed

Price

461.49pre 448.50delayed

$38.3M

Mkt cap

$249.0B

Q2 FY26$2M

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

SCTX15.58vsAMGN461.49Pre-marketNov 6 '26delayed